- Published at
- by gurufocus.com
positive
positive
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
PR NewswireDUBLIN, Feb. 25, 2025
”“ Record total revenues of $4.1 billion in 2024 and $1.1 billion in 4Q24 ”“”“ Xywav® and Epidiolex® revenues grew 16